Earnings Call to Discuss Results to be Conducted Wednesday, November
8 at 8:00 am ET
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Oct. 30, 2017--
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("TARO" or the
"Company") announced today that it plans to release its financial
results for the quarter and six months ended September 30, 2017, on
Tuesday, November 7, 2017.
The Company will conduct an earnings call at 8:00 am EST on Wednesday,
November 8, 2017, where senior management will discuss the Company’s
performance and answer questions from participants.
The release will be accessible on Taro’s website at www.taro.com.
Earnings Call (8:00 am EST on
Wednesday, November 8, 2017)
To participate in this conference call, please dial the numbers provided
below five to ten minutes ahead of the scheduled start time. The
operator will provide instructions on asking questions before the call.
You can also hear the call via an audio webcast, details of which will
be announced later on the Company website, www.taro.com.
A transcript of this earnings call will also be available on the website.
Summary of events
Date and time
Telephone number/ website
November 7, 2017 (AMC)
Earnings conference call
8:00 am EST
November 8, 2017
Participant Toll-Free Dial-In Number: +1 (844) 421-0601
Participant International Dial-In Number: +1 (716) 247-5800
Via audio webcast, details of which will be made available on www.taro.com
Replay of conference call
November 8, 2017 to
November 30, 2017
+ 1 (855) 859-2056 or +1 (404) 537-3406
Via audio webcast playback, details of which will be made
available on www.taro.com
Taro Pharmaceutical Industries Ltd. is a multinational, science-based
pharmaceutical company, dedicated to meeting the needs of its customers
through the discovery, development, manufacturing and marketing of the
highest quality healthcare products. For further information on Taro
Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171030006235/en/
Source: Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd.
Mariano A. Balaguer
AVP, Business Finance, Treasurer and Investor Relations